-
1
-
-
27544490377
-
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
-
Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
-
(2005)
Nat. Immunol.
, vol.6
, pp. 1123-1132
-
-
Harrington, L.E.1
Hatton, R.D.2
Mangan, P.R.3
Turner, H.4
Murphy, T.L.5
Murphy, K.M.6
Weaver, C.T.7
-
2
-
-
27544465354
-
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
-
Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
-
(2005)
Nat. Immunol.
, vol.6
, pp. 1133-1141
-
-
Park, H.1
Li, Z.2
Yang, X.O.3
Chang, S.H.4
Nurieva, R.5
Wang, Y.H.6
Wang, Y.7
Hood, L.8
Zhu, Z.9
Tian, Q.10
Dong, C.11
-
3
-
-
33847206969
-
IL-17 family cytokines and the expanding diversity of effector T cell lineages
-
Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
-
(2007)
Annu. Rev. Immunol.
, vol.25
, pp. 821-852
-
-
Weaver, C.T.1
Hatton, R.D.2
Mangan, P.R.3
Harrington, L.E.4
-
4
-
-
61949463911
-
IL-17 and Th17 Cells
-
Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27: 485-517.
-
(2009)
Annu. Rev. Immunol.
, vol.27
, pp. 485-517
-
-
Korn, T.1
Bettelli, E.2
Oukka, M.3
Kuchroo, V.K.4
-
5
-
-
65749095848
-
Barrier immunity and IL-17
-
Marks, B. R., and J. Craft. 2009. Barrier immunity and IL-17. Semin. Immunol. 21: 164-171.
-
(2009)
Semin. Immunol.
, vol.21
, pp. 164-171
-
-
Marks, B.R.1
Craft, J.2
-
6
-
-
59549083038
-
Interleukin-17 as a drug target in human disease
-
Ivanov, S., and A. Lindén. 2009. Interleukin-17 as a drug target in human disease. Trends Pharmacol. Sci. 30: 95-103.
-
(2009)
Trends Pharmacol. Sci.
, vol.30
, pp. 95-103
-
-
Ivanov, S.1
Lindén, A.2
-
7
-
-
34248572345
-
T(H)-17 cells in the circle of immunity and autoimmunity
-
Bettelli, E., M. Oukka, and V. K. Kuchroo. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8: 345-350.
-
(2007)
Nat. Immunol.
, vol.8
, pp. 345-350
-
-
Bettelli, E.1
Oukka, M.2
Kuchroo, V.K.3
-
8
-
-
5644277476
-
Interleukin-17 family members and inflammation
-
Kolls, J. K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
-
(2004)
Immunity
, vol.21
, pp. 467-476
-
-
Kolls, J.K.1
Lindén, A.2
-
9
-
-
34548459868
-
Structure and function of Toll receptors and their ligands
-
Gay, N. J., and M. Gangloff. 2007. Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem. 76: 141-165.
-
(2007)
Annu. Rev. Biochem.
, vol.76
, pp. 141-165
-
-
Gay, N.J.1
Gangloff, M.2
-
10
-
-
16244376480
-
Toll-like receptors, endogenous ligands, and systemic autoimmune disease
-
Rifkin, I. R., E. A. Leadbetter, L. Busconi, G. Viglianti, and A. Marshak-Rothstein. 2005. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 204: 27-42.
-
(2005)
Immunol. Rev.
, vol.204
, pp. 27-42
-
-
Rifkin, I.R.1
Leadbetter, E.A.2
Busconi, L.3
Viglianti, G.4
Marshak-Rothstein, A.5
-
11
-
-
4344627821
-
Endogenous ligands of Toll-like receptors
-
Tsan, M. F., and B. Gao. 2004. Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76: 514-519.
-
(2004)
J. Leukoc. Biol.
, vol.76
, pp. 514-519
-
-
Tsan, M.F.1
Gao, B.2
-
12
-
-
34948835806
-
TLR4 activation mediates kidney ischemia/reperfusion injury
-
Wu, H., G. Chen, K. R. Wyburn, J. Yin, P. Bertolino, J. M. Eris, S. I. Alexander, A. F. Sharland, and S. J. Chadban. 2007. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117: 2847-2859.
-
(2007)
J. Clin. Invest.
, vol.117
, pp. 2847-2859
-
-
Wu, H.1
Chen, G.2
Wyburn, K.R.3
Yin, J.4
Bertolino, P.5
Eris, J.M.6
Alexander, S.I.7
Sharland, A.F.8
Chadban, S.J.9
-
13
-
-
57349165831
-
Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production
-
Abdollahi-Roodsaz, S., L. A. Joosten, M. M. Helsen, B. Walgreen, P. L. van Lent, L. A. van den Bersselaar, M. I. Koenders, and W. B. van den Berg. 2008. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production. Arthritis Rheum. 58: 3753-3764.
-
(2008)
Arthritis Rheum.
, vol.58
, pp. 3753-3764
-
-
Abdollahi-Roodsaz, S.1
Joosten, L.A.2
Helsen, M.M.3
Walgreen, B.4
Van Lent, P.L.5
Van Den Bersselaar, L.A.6
Koenders, M.I.7
Van Den Berg, W.B.8
-
14
-
-
72549107316
-
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease
-
Rovedatti, L., T. Kudo, P. Biancheri, M. Sarra, C. H. Knowles, D. S. Rampton, G. R. Corazza, G. Monteleone, A. Di Sabatino, and T. T. Macdonald. 2009. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 58: 1629-1636.
-
(2009)
Gut
, vol.58
, pp. 1629-1636
-
-
Rovedatti, L.1
Kudo, T.2
Biancheri, P.3
Sarra, M.4
Knowles, C.H.5
Rampton, D.S.6
Corazza, G.R.7
Monteleone, G.8
Di Sabatino, A.9
Macdonald, T.T.10
-
15
-
-
48849101281
-
The prevalence of Th17 cells in patients with gastric cancer
-
Zhang, B., G. Rong, H. Wei, M. Zhang, J. Bi, L. Ma, X. Xue, G.Wei, X. Liu, and G. Fang. 2008. The prevalence of Th17 cells in patients with gastric cancer. Biochem. Biophys. Res. Commun. 374: 533-537.
-
(2008)
Biochem. Biophys. Res. Commun.
, vol.374
, pp. 533-537
-
-
Zhang, B.1
Rong, G.2
Wei, H.3
Zhang, M.4
Bi, J.5
Ma, L.6
Xue, X.7
Wei, G.8
Liu, X.9
Fang, G.10
-
16
-
-
0032403506
-
IL-17 stimulates granulopoiesis in mice: Use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines
-
Schwarzenberger, P., V. La Russa, A. Miller, P. Ye, W. Huang, A. Zieske, S. Nelson, G. J. Bagby, D. Stoltz, R. L. Mynatt, et al. 1998. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 161: 6383-6389.
-
(1998)
J. Immunol.
, vol.161
, pp. 6383-6389
-
-
Schwarzenberger, P.1
La Russa, V.2
Miller, A.3
Ye, P.4
Huang, W.5
Zieske, A.6
Nelson, S.7
Bagby, G.J.8
Stoltz, D.9
Mynatt, R.L.10
-
17
-
-
0347285363
-
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
-
Lecker, S. H., R. T. Jagoe, A. Gilbert, M. Gomes, V. Baracos, J. Bailey, S. R. Price, W. E. Mitch, and A. L. Goldberg. 2004. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 18: 39-51.
-
(2004)
FASEB J.
, vol.18
, pp. 39-51
-
-
Lecker, S.H.1
Jagoe, R.T.2
Gilbert, A.3
Gomes, M.4
Baracos, V.5
Bailey, J.6
Price, S.R.7
Mitch, W.E.8
Goldberg, A.L.9
-
18
-
-
0033557728
-
Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways
-
Laan, M., Z. H. Cui, H. Hoshino, J. Lötvall, M. Sjöstrand, D. C. Gruenert, B. E. Skoogh, and A. Lindén. 1999. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162: 2347-2352. (Pubitemid 29288861)
-
(1999)
Journal of Immunology
, vol.162
, Issue.4
, pp. 2347-2352
-
-
Laan, M.1
Cui, Z.-H.2
Hoshino, H.3
Lotvall, J.4
Sjostrand, M.5
Gruenert, D.C.6
Skoogh, B.-E.7
Linden, A.8
-
19
-
-
17944364849
-
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense
-
Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194: 519-527.
-
(2001)
J. Exp. Med.
, vol.194
, pp. 519-527
-
-
Ye, P.1
Rodriguez, F.H.2
Kanaly, S.3
Stocking, K.L.4
Schurr, J.5
Schwarzenberger, P.6
Oliver, P.7
Huang, W.8
Zhang, P.9
Zhang, J.10
-
20
-
-
34147126728
-
An essential role for IL-17 in preventing pathogen-initiated bone destruction: Recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals
-
Yu, J. J., M. J. Ruddy, G. C. Wong, C. Sfintescu, P. J. Baker, J. B. Smith, R. T. Evans, and S. L. Gaffen. 2007. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109: 3794-3802.
-
(2007)
Blood
, vol.109
, pp. 3794-3802
-
-
Yu, J.J.1
Ruddy, M.J.2
Wong, G.C.3
Sfintescu, C.4
Baker, P.J.5
Smith, J.B.6
Evans, R.T.7
Gaffen, S.L.8
-
21
-
-
67649982995
-
Mechanisms of cancer cachexia
-
Tisdale, M. J. 2009. Mechanisms of cancer cachexia. Physiol. Rev. 89: 381-410.
-
(2009)
Physiol. Rev.
, vol.89
, pp. 381-410
-
-
Tisdale, M.J.1
-
22
-
-
0023916786
-
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation
-
Tracey, K. J., H. Wei, K. R. Manogue, Y. Fong, D. G. Hesse, H. T. Nguyen, G. C. Kuo, B. Beutler, R. S. Cotran, A. Cerami, et al. 1988. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167: 1211-1227.
-
(1988)
J. Exp. Med.
, vol.167
, pp. 1211-1227
-
-
Tracey, K.J.1
Wei, H.2
Manogue, K.R.3
Fong, Y.4
Hesse, D.G.5
Nguyen, H.T.6
Kuo, G.C.7
Beutler, B.8
Cotran, R.S.9
Cerami, A.10
-
23
-
-
0026689535
-
Evidence for the involvement of interleukin 6 in experimental cancer cachexia
-
Strassmann, G., M. Fong, J. S. Kenney, and C. O. Jacob. 1992. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest. 89: 1681-1684.
-
(1992)
J. Clin. Invest.
, vol.89
, pp. 1681-1684
-
-
Strassmann, G.1
Fong, M.2
Kenney, J.S.3
Jacob, C.O.4
-
24
-
-
65249111038
-
Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production
-
Lemos, H. P., R. Grespan, S. M. Vieira, T. M. Cunha, W. A. Verri, Jr., K. S. Fernandes, F. O. Souto, I. B. McInnes, S. H. Ferreira, F. Y. Liew, and F. Q. Cunha. 2009. Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc. Natl. Acad. Sci. USA 106: 5954-5959.
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 5954-5959
-
-
Lemos, H.P.1
Grespan, R.2
Vieira, S.M.3
Cunha, T.M.4
Verri Jr., W.A.5
Fernandes, K.S.6
Souto, F.O.7
McInnes, I.B.8
Ferreira, S.H.9
Liew, F.Y.10
Cunha, F.Q.11
-
25
-
-
0034669270
-
IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells
-
Witowski, J., K. Pawlaczyk, A. Breborowicz, A. Scheuren, M. Kuzlan-Pawlaczyk, J. Wisniewska, A. Polubinska, H. Friess, G. M. Gahl, U. Frei, and A. Jörres. 2000. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J. Immunol. 165: 5814-5821.
-
(2000)
J. Immunol.
, vol.165
, pp. 5814-5821
-
-
Witowski, J.1
Pawlaczyk, K.2
Breborowicz, A.3
Scheuren, A.4
Kuzlan-Pawlaczyk, M.5
Wisniewska, J.6
Polubinska, A.7
Friess, H.8
Gahl, G.M.9
Frei, U.10
Jörres, A.11
-
26
-
-
0037351927
-
Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors
-
Fan, J., and A. B. Malik. 2003. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nat. Med. 9: 315-321.
-
(2003)
Nat. Med.
, vol.9
, pp. 315-321
-
-
Fan, J.1
Malik, A.B.2
-
27
-
-
0037883695
-
Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span
-
Sabroe, I., L. R. Prince, E. C. Jones, M. J. Horsburgh, S. J. Foster, S. N. Vogel, S. K. Dower, and M. K. Whyte. 2003. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J. Immunol. 170: 5268-5275.
-
(2003)
J. Immunol.
, vol.170
, pp. 5268-5275
-
-
Sabroe, I.1
Prince, L.R.2
Jones, E.C.3
Horsburgh, M.J.4
Foster, S.J.5
Vogel, S.N.6
Dower, S.K.7
Whyte, M.K.8
-
28
-
-
33646882893
-
Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis
-
Roelofs, M. F., W. C. Boelens, L. A. Joosten, S. Abdollahi-Roodsaz, J. Geurts, L. U. Wunderink, B. W. Schreurs, W. B. van den Berg, and T. R. Radstake. 2006. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J. Immunol. 176: 7021-7027.
-
(2006)
J. Immunol.
, vol.176
, pp. 7021-7027
-
-
Roelofs, M.F.1
Boelens, W.C.2
Joosten, L.A.3
Abdollahi-Roodsaz, S.4
Geurts, J.5
Wunderink, L.U.6
Schreurs, B.W.7
Van Den Berg, W.B.8
Radstake, T.R.9
-
29
-
-
0242584872
-
Cutting edge: Roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection
-
Happel, K. I., M. Zheng, E. Young, L. J. Quinton, E. Lockhart, A. J. Ramsay, J. E. Shellito, J. R. Schurr, G. J. Bagby, S. Nelson, and J. K. Kolls. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170: 4432-4436.
-
(2003)
J. Immunol.
, vol.170
, pp. 4432-4436
-
-
Happel, K.I.1
Zheng, M.2
Young, E.3
Quinton, L.J.4
Lockhart, E.5
Ramsay, A.J.6
Shellito, J.E.7
Schurr, J.R.8
Bagby, G.J.9
Nelson, S.10
Kolls, J.K.11
-
30
-
-
38149048556
-
Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis
-
Abdollahi-Roodsaz, S., L. A. Joosten, M. I. Koenders, I. Devesa, M. F. Roelofs, T. R. Radstake, M. Heuvelmans-Jacobs, S. Akira, M. J. Nicklin, F. Ribeiro-Dias, and W. B. van den Berg. 2008. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Invest. 118: 205-216.
-
(2008)
J. Clin. Invest.
, vol.118
, pp. 205-216
-
-
Abdollahi-Roodsaz, S.1
Joosten, L.A.2
Koenders, M.I.3
Devesa, I.4
Roelofs, M.F.5
Radstake, T.R.6
Heuvelmans-Jacobs, M.7
Akira, S.8
Nicklin, M.J.9
Ribeiro-Dias, F.10
Van Den Berg, W.B.11
-
31
-
-
66149153423
-
Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis
-
Lee, J. H., M. L. Cho, J. I. Kim, Y. M. Moon, H. J. Oh, G. T. Kim, S. Ryu, S. H. Baek, S. H. Lee, H. Y. Kim, and S. I. Kim. 2009. Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis. J. Rheumatol. 36: 684-692.
-
(2009)
J. Rheumatol.
, vol.36
, pp. 684-692
-
-
Lee, J.H.1
Cho, M.L.2
Kim, J.I.3
Moon, Y.M.4
Oh, H.J.5
Kim, G.T.6
Ryu, S.7
Baek, S.H.8
Lee, S.H.9
Kim, H.Y.10
Kim, S.I.11
|